This inventor holds 4 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1985-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985-1996
Title: Yasuo Nakayama: Pharmaceutical Inventions and Patent Contributions.
Introduction
Yasuo Nakayama is an inventor associated with Tokushima, Japan, and Otsuka Pharmaceutical Company, Limited. His recorded portfolio includes 4 patents, with inventions focused on pharmaceutical compositions and antibodies related to interleukin-1.
Latest Patents
Among Nakayama’s listed patents is “Stabilized IL-1α Medicinal Composition,” concerning a pharmaceutical composition designed to stabilize interleukin-1α.
Another listed invention is “Monoclonal Antibody Specific for Human Interleukin-1β and Method.” It describes a monoclonal antibody that specifically reacts with human IL-1β, a process for producing the antibody, and a method for detecting biologically active human IL-1β.
Career Highlights
Nakayama’s patent work reflects research into biologically active substances and their potential pharmaceutical applications. His listed affiliation with Otsuka Pharmaceutical Company, Limited, connects his inventive activity with a company engaged in pharmaceutical research and development.
Collaborations
Wasei Miyazaki and Tadao Sato are identified as Nakayama’s coworkers, indicating professional connections within his research and development environment.
Conclusion
Yasuo Nakayama’s recorded inventions center on interleukin-related pharmaceutical compositions and antibody technology, representing a focused contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile